Peptide Therapy in Los Angeles
US$ 28.79
bpc 157 evidence human clinical trials safety ππ»ββοΈ Is the lack of data in BPC-157 a red flag? β’ If a drug could actually knit torn tendons back together in weeks, a trillion-dollar pharmaceutical industry probably wouldn't bury BPC-157 β No Proof Required!
Description
Disclosure of interest: No conflict of interest Poster session II - DIAGNOSIS / ETIOLOGY 04.00 - DIAGNOSIS / ETIOLOGY - 04.04 - RARE CAUSES INCL
For both peptides, the primary safety concern is source quality, not the molecules themselves
We've chosen to use each peptide where research suggests it's most effective
T.KalisvaartK
